Literature DB >> 3393661

Mediastinal lymph nodes: relaxation time/pathologic correlation and implications in staging of lung cancer with MR imaging.

G M Glazer1, M B Orringer, T L Chenevert, J A Borrello, M W Penner, L E Quint, K C Li, A M Aisen.   

Abstract

The authors measured the T1 and T2 relaxation times of freshly excised human mediastinal lymph nodes to determine whether the times are clinically useful in distinguishing benign from malignant nodes. All measurements were performed at 20 MHz and 40 degrees C, within 45 minutes of lymph node excision. Mean T1 and T2 relaxation times of 99 benign nodes were 566 msec (standard deviation [SD], 117 msec) and 92 msec (SD, 29 msec), respectively. For the 16 malignant nodes, these times were 640 msec (SD, 138 msec) and 105 msec (SD, 26 msec), respectively (P less than .05 for difference in T1 times, P greater than .05 for difference in T2 times). Histograms showed considerable overlap in the relaxation times of benign and malignant nodes such that absolute measurement of these times will likely be of limited clinical value.

Entities:  

Mesh:

Year:  1988        PMID: 3393661     DOI: 10.1148/radiology.168.2.3393661

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  5 in total

Review 1.  Oncology imaging: nodal spread-intrathoracic nodes.

Authors:  J A Verschakelen; P de Leyn; J Bogaert; A L Baert
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

Review 2.  Defining the role of modern imaging techniques in assessing lymph nodes for metastasis in cancer: evolving contribution of PET in this setting.

Authors:  Thomas C Kwee; Sandip Basu; Drew A Torigian; Babak Saboury; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-01-12       Impact factor: 9.236

3.  A proposal for combined MRI and PET/CT interpretation criteria for preoperative nodal staging in non-small-cell lung cancer.

Authors:  Yoo Na Kim; Chin A Yi; Kyung Soo Lee; O Jung Kwon; Ho Yun Lee; Byung-Tae Kim; Joon Young Choi; Seon Woo Kim; Man Pyo Chung; Joungho Han; Tae Sung Kim; Myung Jin Chung; Young Mog Shim
Journal:  Eur Radiol       Date:  2012-02-26       Impact factor: 5.315

4.  Ferumoxtran-10, a superparamagnetic iron oxide as a magnetic resonance enhancement agent for imaging lymph nodes: a phase 2 dose study.

Authors:  Patricia A Hudgins; Yoshimi Anzai; Marie R Morris; Maria A Lucas
Journal:  AJNR Am J Neuroradiol       Date:  2002-04       Impact factor: 3.825

Review 5.  Staging of bronchogenic carcinoma.

Authors:  S J Herman
Journal:  World J Surg       Date:  1993 Nov-Dec       Impact factor: 3.352

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.